Alok B.
- Country
- Norway
- Department
- Department of Neurology
Research Overview
Data & Insights
Has run more than one trial at 0 of 5 partner sites.
Specializations
Neurology and multiple sclerosis
Clinical research activity includes multiple sclerosis, relapsing-remitting multiple sclerosis, and therapies aimed at reducing neuronal damage and improving disease control in neuroinflammatory conditions.
- Ocrelizumab
- Rituximab
- Tenofovir alafenamide
- Anti-CD20 therapy
Work also extends to treatment effectiveness in people previously enrolled in multiple sclerosis clinical programs.
Cerebrovascular disease and cardiovascular risk
Research interests include prevention of stroke and systemic embolism in patients with atrial fibrillation, including those with advanced chronic kidney disease and dialysis-related complexity.
- Apixaban
- Asundexian
- Chronic kidney disease stage 5
- Anticoagulation
Additional involvement covers broader cardiovascular disease and prevention strategies in high-risk arrhythmia settings.
Oncology and hematologic malignancies
The investigator is engaged in studies across solid tumors and blood cancers, with emphasis on immunotherapy, targeted treatment, and disease-specific outcomes in advanced and recurrent malignancies.
- Non-small cell lung cancer
- Multiple myeloma
- Acute myeloid leukemia
- Breast cancer
Therapeutic interests also include lymphoma, melanoma, urothelial carcinoma, and gastrointestinal cancers.
Infectious disease and respiratory medicine
Clinical trial involvement includes management of COVID-19, mpox virus disease, and other respiratory infections, with attention to treatment effects in hospitalized and community settings.
- Tecovirimat
- Baricitinib
- Antiviral therapy
- Lower respiratory tract infection
Research also touches on pediatric chronic wet cough and infection-related inflammatory disease.
Autoimmune, inflammatory, and metabolic disorders
Additional research spans immune-mediated and chronic inflammatory diseases, including psoriasis, hidradenitis suppurativa, rheumatoid arthritis, juvenile idiopathic arthritis, and systemic lupus erythematosus.
- Semaglutide
- Ziltivekimab
- Spesolimab
- Therapeutic drug monitoring
Interest also includes heart failure with inflammation, obesity, and metabolic control in psychiatric and endocrine contexts.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.